TITLE

Vigabatrin Inhibits Seizures and mTOR Pathway Activation in a Mouse Model of Tuberous Sclerosis Complex

AUTHOR(S)
Zhang, Bo; McDaniel, Sharon S.; Rensing, Nicholas R.; Wong, Michael
PUB. DATE
February 2013
SOURCE
PLoS ONE;Feb2013, Vol. 8 Issue 2, p1
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
Epilepsy is a common neurological disorder and cause of significant morbidity and mortality. Although antiseizure medication is the first-line treatment for epilepsy, currently available medications are ineffective in a significant percentage of patients and have not clearly been demonstrated to have disease-specific effects for epilepsy. While seizures are usually intractable to medication in tuberous sclerosis complex (TSC), a common genetic cause of epilepsy, vigabatrin appears to have unique efficacy for epilepsy in TSC. While vigabatrin increases gamma-aminobutyric acid (GABA) levels, the precise mechanism of action of vigabatrin in TSC is not known. In this study, we investigated the effects of vigabatrin on epilepsy in a knock-out mouse model of TSC and tested the novel hypothesis that vigabatrin inhibits the mammalian target of rapamycin (mTOR) pathway, a key signaling pathway that is dysregulated in TSC. We found that vigabatrin caused a modest increase in brain GABA levels and inhibited seizures in the mouse model of TSC. Furthermore, vigabatrin partially inhibited mTOR pathway activity and glial proliferation in the knock-out mice in vivo, as well as reduced mTOR pathway activation in cultured astrocytes from both knock-out and control mice. This study identifies a potential novel mechanism of action of an antiseizure medication involving the mTOR pathway, which may account for the unique efficacy of this drug for a genetic epilepsy.
ACCESSION #
87625460

 

Related Articles

  • Do We Have a Cure for Tuberous Sclerosis Complex? Crino, Peter B. // Epilepsy Currents;Nov/Dec2008, Vol. 8 Issue 6, p159 

    The recent development of several mouse models for tuberous sclerosis complex (TSC) provides in vivo systems to test new therapies for the neurological manifestations of TSC. Rapamycin is known to antagonize the effects of loss of TSC protein function in vitro and in mouse TSC models, rapamycin...

  • Infantile Spasms: Therapy and Outcome. Riikonen, Raili // Journal of Child Neurology;Jun2004, Vol. 19 Issue 6, p401 

    Up-to date information about corticotropin (ACTH) in the treatment of infantile spasms and evaluation of the long-term outcome was provided to answer questions about (1) the efficacy of doses of ACTH in comparison with other drugs, especially with vigabatrin, and the efficacy in patients with...

  • Neurogenin 3--Directed Cre Deletion of Tsc1 Gene Causes Pancreatic Acinar Carcinoma. Li Ding; Lingling Han; Yin Li; Jing Zhao; Ping He; Weizhen Zhang // Neoplasia;Nov2014, Vol. 16 Issue 11, p909 

    The role of tuberous sclerosis complex (TSC) in the pathogenesis of pancreatic cancers remains largely unknown. The present study shows that neurogenin 3 directed Cre deletion of Tsc1 gene induces the development of pancreatic acinar carcinoma. By cross-breeding the Neurog3-cre mice with...

  • Vigabatrin and Mental Retardation in Tuberous Sclerosis: Infantile Spasms Versus Focal Seizures. Yum, Mi-Sun; Lee, Eun Hye; Ko, Tae-Sung // Journal of Child Neurology;Mar2013, Vol. 28 Issue 3, p308 

    Tuberous sclerosis complex is a genetic disorder resulting in epilepsy and mental retardation. Vigabatrin has shown efficacy in the treatment of infantile spasms caused by tuberous sclerosis complex, but its effects on focal seizures caused by tuberous sclerosis complex have not been determined....

  • Tuberous Sclerosis. MOLLAH, M. A. H.; RAHMAN, S. // Journal of Bangladesh College of Physicians & Surgeons;Oct2013, Vol. 31 Issue 4, p230 

    The article discusses a case of a 12 1/2-year-old boy with seizures and was found apathetic and mentally ill. Topics include the red nodular angio-fibromas on the patient's nose and cheeks, performing Electroencephalography (EEG) and computed tomography (CT) scan of the patient's brain, and the...

  • The Current Evaluation and Treatment of Infantile Spasms Among Members of the Child Neurology Society. Mytinger, John R.; Joshi, Sucheta // Journal of Child Neurology;Oct2012, Vol. 27 Issue 10, p1289 

    The optimal evaluation and treatment of children with infantile spasms is unknown. To aid in the development of a standardized approach to infantile spasms, members of the Child Neurology Society were surveyed to determine common practice. The survey had 222 responders with a responder rate of...

  • Real-Time Monitoring of Tumorigenesis, Dissemination, & Drug Response in a Preclinical Model of Lymphangioleiomyomatosis/Tuberous Sclerosis Complex. Fangbing Liu; Lunsford, Elaine P.; Tong, Jingli; Ashitate, Yoshitomo; Gibbs, Summer L.; Jane Yu; Soo Choi, Hak; Henske, Elizabeth P.; Frangioni, John V. // PLoS ONE;Jun2012, Vol. 7 Issue 6, p1 

    Background: TSC2-deficient cells can proliferate in the lungs, kidneys, and other organs causing devastating progressive multisystem disorders such as lymphangioleiomyomatosis (LAM) and tuberous sclerosis complex (TSC). Preclinical models utilizing LAM patient-derived cells have been difficult...

  • Vigabatrin.  // Reactions Weekly;6/4/2011, Issue 1354, p41 

    The article describes the case of a six-month-old boy with infantile spasms and tuberous sclerosis complex who developed asymptomatic diffusion abnormalities in his bilateral thalami, globus pallidi and brainstem due to vigabatrin treatment.

  • Tuberous sclerosis complex inactivation disrupts melanogenesis via mTORC1 activation. Juxiang Cao; Tyburczy, Magdalena E.; Moss, Joel; Darling, Thomas N.; Widlund, Hans R.; Kwiatkowski, David J.; Cao, Juxiang // Journal of Clinical Investigation;Jan2017, Vol. 127 Issue 1, p349 

    Tuberous sclerosis complex (TSC) is an autosomal dominant tumor-suppressor gene syndrome caused by inactivating mutations in either TSC1 or TSC2, and the TSC protein complex is an essential regulator of mTOR complex 1 (mTORC1). Patients with TSC develop hypomelanotic macules (white spots), but...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics